Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

50.76
-0.1100-0.22%
Post-market: 50.760.00000.00%19:30 EDT
Volume:53.93K
Turnover:2.73M
Market Cap:1.73B
PE:10.39
High:51.21
Open:50.91
Low:50.06
Close:50.87
52wk High:54.29
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:0.71
T/O Rate:0.19%
Dividend:3.06
Dividend Rate:6.02%
EPS(TTM):4.89
EPS(LYR):2.11
ROE:27.21%
ROA:5.25%
PB:2.57
PE(LYR):24.06

Loading ...

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

GlobeNewswire
·
Jun 30

CVS Health (CVS) Following GLP 1 Launch Faces A Fresh Valuation Test

Simply Wall St.
·
Jun 30

Global Partners to Redeem USD 75 Million Series B Preferred Units on July 30, 2026

Reuters
·
Jun 30

Global Partners Lp - Series B Preferred Units to be Redeemed at $25 Per Share Plus Accrued Distributions

THOMSON REUTERS
·
Jun 30

Global Partners Lp Announces Full Redemption of Series B Fixed Rate Cumulative Redeemable Perpetual Preferred Units

THOMSON REUTERS
·
Jun 30

Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026

GlobeNewswire
·
Jun 29

GLP J-REIT Locks in Fixed Rates for 2.18 Billion Yen in New Borrowings

MT Newswires Live
·
Jun 26

Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing

TIPRANKS
·
Jun 25

Lexaria Bioscience begins dosing in animal study GLP-1-A26-1

TIPRANKS
·
Jun 23

How Investors May Respond To CVS (CVS) Expanding GLP-1 Support And Virtual Chronic Care Services

Simply Wall St.
·
Jun 23

ASCLETIS-B Receives FDA Clearance for Phase I Study of Its Monthly Subcutaneous GLP-1R/GIPR Dual Agonist Peptide ASC35 in Obesity

Stock News
·
Jun 23

Global GP acquires $431,050 of Global Partners common units

Reuters
·
Jun 23

CVS Health Expands GLP-1 Support for Patients

Dow Jones
·
Jun 22

CVS Health announces comprehensive approach to GLP-1 support

TIPRANKS
·
Jun 22

Swiss Voters Reject Population Cap Initiative, Highlighting Europe's Enduring Immigration Dilemma

Deep News
·
Jun 19

GLP J-REIT Secures 26 Billion Yen Refinancing

MT Newswires Live
·
Jun 19

NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets

GlobeNewswire
·
Jun 18

GLP J-REIT refinances ¥26.2bn debt, extends loan maturities to 2032

TIPRANKS
·
Jun 18

Global GP LLC acquires $466,950 of Global Partners common units

Reuters
·
Jun 17

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

GlobeNewswire
·
Jun 16